Cartesian Therapeutics, Inc. · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

1 of 6≥ implied

Nov 7 '24—▼−0.38%—

Mar 13 '25—▼−4.98%—

May 8 '25±29.1%▲+2.66%×0.09

Aug 7 '25±35.5%▼−6.56%×0.18

Nov 6 '25±40.4%▼−1.56%×0.04

Q1 FY26±31.0%▲+31.68%×1.02

Apr 30 '26±52.8%▼−3.86%×0.07

Q2 FY26±16.9%▲+4.91%×0.29

quarterimplied−55%0+55%realized×

Q2 FY26±16.9%▲+4.91%×0.29

Apr '26±52.8%▼−3.86%×0.07

Q1 FY26±31.0%▲+31.68%×1.02

Nov '25±40.4%▼−1.56%×0.04

Aug '25±35.5%▼−6.56%×0.18

May '25±29.1%▲+2.66%×0.09

2 older reports

Mar '25—▼−4.98%—

Nov '24—▼−0.38%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2 of 4

8disclosed supplier and customer ties in SEC filingsSEC filings

95managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

15managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

0.00%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

RNAC report session

No linked exposure.

Oct 22impliedImplied move: ±84.2% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.